Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Samsung Electronics...

    Samsung Electronics issues apology for factory cancer cases

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-24T13:18:41+05:30  |  Updated On 24 Nov 2018 1:18 PM IST
    Samsung Electronics issues apology for factory cancer cases
    South Korean activist group Sharps claims around 200 workers have fallen ill after working at Samsung plants and 70 of them have died subsequently.

    New Delhi: Samsung Electronics apologised on Friday to workers who developed cancer after working at its semiconductor factories, ending a decade-long dispute at the world's top chipmaker. "We sincerely apologise to the workers who suffered from illness and their families," said Samsung co-president Kim Ki-nam.


    "We have failed to properly manage health risks at our semiconductor and LCD factories." Campaign groups say that 320 people have suffered from work-related illnesses after being employed by Samsung, with 118 of them dying.

    Under a deal announced earlier this month, the firm will pay compensation of up to 150 million won (USD 133,000) per case.

    It covers 16 types of cancer, some other rare illnesses, miscarriages and congenital diseases suffered by the workers' children.

    The scandal emerged in 2007 when former workers at its semiconductor and display factories in Suwon, south of Seoul, and their families said that staff had been diagnosed or died of various forms of cancer.

    A series of rulings and decisions by courts, Seoul's state labour welfare agency and a mediation committee followed over more than 10 years, culminating in Friday's announcement.

    Relatives' leader Hwang Sang-gi, whose 22-year-old son died of leukaemia, said on Friday: "The apology honestly was not enough for the families of the victims but we will accept it."

    Hwang Sang-ki, the founder of Sharps and father of a dead chip factory worker with leukaemia, told Reuters that besides those 200 he expected more workers to apply for compensation, but it would take a long medical process to prove their diseases are directly related to the work environment.

    South Korean activist group Sharps claims around 200 workers have fallen ill after working at Samsung plants and 70 of them have died subsequently.

    “Our effort was insufficient to better understand the pain affected workers and their families went through,” Samsung Electronics Chief Executive Kim Ki-nam said in a public apology during an event to sign the agreement with the advocacy group, reports Reuters.

    Kim said the company would post its compensation guidelines along with an apology letter by at the end of this month on the company’s website and an independent Seoul-based law firm will conduct the review process for affected workers for their compensation eligibility.

    Also Read: Samsung to set up 15 Smart Healthcare centers in Tamil Nadu
    cancerhealth issueshealth risksKim Ki-namSamsungsamsung cancerSamsung Electronicswang Sang-ki
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok